Qube Research & Technologies (QRT)’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.7M Sell
3,600
-3,800
-51% -$1.91M ﹤0.01% 2259
2025
Q4
$3.45M Buy
7,400
+3,000
+68% +$1.39M ﹤0.01% 1978
2025
Q3
$1.88M Sell
4,400
-3,400
-44% -$1.32M ﹤0.01% 2262
2025
Q2
$2.99M Buy
7,800
+6,700
+609% +$2.41M ﹤0.01% 1993
2025
Q1
$380K Sell
1,100
-1,600
-59% -$515K ﹤0.01% 2651
2024
Q4
$810K Buy
2,700
+2,200
+440% +$769K ﹤0.01% 2278
2024
Q3
$203K Buy
+500
New +$183K ﹤0.01% 2581
2024
Q1
Sell
-2,800
Closed -$758K 4638
2023
Q4
$758K Sell
2,800
-29,500
-91% -$7.29M ﹤0.01% 2073
2023
Q3
$7.95M Buy
+32,300
New +$8.84M 0.02% 731

Other funds holding HCA

Qube Research & Technologies (QRT)'s HCA Position: Q1 2026 in Review

Qube Research & Technologies (QRT) reduced its HCA Healthcare (HCA) stake by 9.2% in Q1 2026, selling an estimated $9.39M and leaving 183,870 shares worth $87M. The position accounts for 0.1% of the portfolio, ranked #249.

Qube Research & Technologies (QRT) first reported a position in HCA in Q2 2018 and has held it in 24 quarters since. The position peaked at $310M in Q4 2024. 1,414 funds tracked by Wall St. Rank hold HCA as of Q1 2026.

  • Qube Research & Technologies (QRT) held 183,870 shares of HCA Healthcare worth $87M as of Q1 2026.
  • Qube Research & Technologies (QRT) sold 18,655 HCA Healthcare shares in Q1 2026, an estimated $9.39M.
  • HCA Healthcare made up 0.1% of Qube Research & Technologies (QRT)'s portfolio in Q1 2026, its #249 holding.
  • Qube Research & Technologies (QRT) first reported a position in HCA Healthcare in Q2 2018 and has held it in 24 quarters since.
  • Qube Research & Technologies (QRT)'s HCA Healthcare position peaked at $310M in Q4 2024.
  • 1,414 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2026, filed 15 May 2026.